M
M. Bagchi
Researcher at Creighton University Medical Center
Publications - 7
Citations - 226
M. Bagchi is an academic researcher from Creighton University Medical Center. The author has contributed to research in topics: Osteoarthritis & Chondroitin. The author has an hindex of 6, co-authored 7 publications receiving 171 citations.
Papers
More filters
Journal ArticleDOI
Comparative therapeutic efficacy and safety of type‐II collagen (uc‐II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate
Ramesh C. Gupta,T. D. Canerdy,J. Lindley,M. Konemann,J. Minniear,B. A. Carroll,C. Hendrick,John T. Goad,K. Rohde,Robin B. Doss,M. Bagchi,Debasis Bagchi +11 more
TL;DR: In this paper, the authors evaluated the therapeutic efficacy of type-II collagen (UC-II) alone or in combination with glucosamine hydrochloride (GLU) and chondroitin sulphate (CHO), and determined their tolerability and safety.
Journal ArticleDOI
Therapeutic Efficacy and Safety of Undenatured Type II Collagen Singly or in Combination with Glucosamine and Chondroitin in Arthritic Dogs
M. D'altilio,A. Peal,M. Alvey,C. Simms,A. Curtsinger,Ramesh C. Gupta,T. D. Canerdy,John T. Goad,M. Bagchi,Debasis Bagchi +9 more
TL;DR: Data of this placebo-controlled study demonstrate that daily treatment of arthritic dogs with UC-II alone or in combination with glucosamine and chondroitin markedly alleviatesArthritic-associated pain, and these supplements are well tolerated as no side effects were noted.
Journal ArticleDOI
Efficacy and safety of glycosylated undenatured type‐II collagen (UC‐II) in therapy of arthritic dogs§
L. A. Deparle,Ramesh C. Gupta,T. D. Canerdy,John T. Goad,M. D'altilio,M. Bagchi,Debasis Bagchi +6 more
TL;DR: It is suggested that daily treatment of arthritic dogs with UC-II ameliorates signs and symptoms of arthritis, andUC-II is well tolerated as no adverse effects were noted.
Journal ArticleDOI
Therapeutic efficacy of undenatured type-II collagen (UC-II) in comparison to glucosamine and chondroitin in arthritic horses.
Ramesh C. Gupta,T. D. Canerdy,P. Skaggs,A. Stocker,G. Zyrkowski,R. Burke,K. Wegford,John T. Goad,K. Rohde,Dale Barnett,W. Dewees,M. Bagchi,Debasis Bagchi +12 more
TL;DR: Arthritic pain in horses receiving daily placebo, undenatured type II collagen (UC-II) at 320, 480, or 640 mg (providing 80, 120, and 160 mg active UC-II, respectively), and glucosamine and chondroitin (5.4 and 1.8 g, respectively, bid for the first month, and thereafter once daily) for 150 days was evaluated.